Belgium-based Sunrise Group Raises $29M Funding

The funding round was led by Eurazeo, with participation from Amazon’s Alexa Fund, WE International, Kurma Partners, Vives Fund, Majycc, Namur Invest, Seventure Partners, Investsud, Sambrinvest, Noshaq, IMBC, and Invest.BW.

The proceeds will support Dreem Health’s U.S. expansion, broaden clinical services, and drive the development of next-generation sleep technology.

“What sets Sunrise Group apart is the combination of hardware and software built specifically for sleep health technology that directly powers Dreem Health’s clinical services,” said Maxime Huerre, VP venture at Eurazeo, in a statement. “It’s not just another app or device. It’s the backbone of a new, scalable model for how sleep care will be delivered.”

Read Also - London-based Checkout.com Announces Employee Share Buyback At $12 Billion Valuation

Led by CEO and Founder Laurent Martinot, Sunrise Group focuses on sleep health technology. The company developed an FDA-cleared mandibular movement sensor, a lightweight at-home device for diagnosing sleep apnea, validated by peer-reviewed studies and endorsed by leading sleep experts.

Sunrise combines advanced hardware and software to detect, monitor, and treat sleep disorders, bringing this expertise to Dreem Health, its U.S. digital sleep clinic. Headquartered in Belgium with offices in France and the U.S., the team unites experts in sleep research, patient care, and medical technology.

“validating the accuracy and effectiveness of our home sleep test when compared to traditional polysomnography,” said Laurent Martinot, CEO and founder of the Sunrise Group.

About Sunrise

Founded in 2015, Sunrise is transforming sleep health. Starting with a peer-reviewed, at-home chin sensor for accurate sleep diagnosis, the company now offers Dreem Health’s digital platform, providing end-to-end care screening, diagnosing, and treating sleep disorders making sleep medicine more accessible, comfortable, and effective from home.